Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
BCPC Stock Forecast 2025-2026
$152.56
Current Price
$4.94B
Market Cap
Buy 2
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to BCPC Price Targets
+44.2%
To High Target of $220.00
+25.9%
To Median Target of $192.00
+24.5%
To Low Target of $190.00
BCPC Price Momentum
-0.5%
1 Week Change
+8.7%
1 Month Change
-14.9%
1 Year Change
-6.4%
Year-to-Date Change
-18.0%
From 52W High of $185.96
+9.6%
From 52W Low of $139.17
📊 TOP ANALYST CALLS
Did BCPC Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Balchem is one of their latest high-conviction picks.
Latest BCPC Stock Price Targets & Analyst Predictions
Based on our analysis of 3 Wall Street analysts, BCPC has a bullish consensus with a median price target of $192.00 (ranging from $190.00 to $220.00). The overall analyst rating is N/A (N/A/10). Currently trading at $152.56, the median forecast implies a 25.9% upside. This outlook is supported by 2 Buy, 0 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Raghuram Selvaraju at HC Wainwright & Co., suggesting a 24.5% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
BCPC Analyst Ratings
2
Buy
0
Hold
0
Sell
BCPC Price Target Range
Low
$190.00
Average
$192.00
High
$220.00
Current: $152.56
Latest BCPC Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for BCPC.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Oct 22, 2025 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $190.00 |
| Aug 4, 2025 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $189.00 |
| Apr 28, 2025 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $180.00 |
| Feb 24, 2025 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Reiterates | $190.00 |
| Nov 4, 2024 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $190.00 |
| Jul 31, 2024 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $185.00 |
| May 6, 2024 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $170.00 |
| Feb 20, 2024 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Oct 30, 2023 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $135.00 |
| Jul 31, 2023 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $165.00 |
| Jun 5, 2023 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $150.00 |
| Feb 27, 2023 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $140.00 |
| Nov 7, 2022 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $152.00 |
| Aug 22, 2022 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $164.00 |
| May 2, 2022 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $152.00 |
| Mar 8, 2022 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $155.00 |
| Feb 22, 2022 | Sidoti & Co. | Buy | Upgrade | $N/A | |
| Jan 10, 2022 | HC Wainwright & Co. | Buy | Maintains | $170.00 | |
| Nov 29, 2021 | Sidoti & Co. | Neutral | Downgrade | $N/A | |
| Aug 2, 2021 | Stephens & Co. | Mark Connelly | Equal-Weight | Downgrade | $145.00 |
Balchem Corporation (BCPC) Competitors
The following stocks are similar to Balchem based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Balchem Corporation (BCPC) Financial Data
Balchem Corporation has a market capitalization of $4.94B with a P/E ratio of 33.3x. The company generates $1.01B in trailing twelve-month revenue with a 14.7% profit margin.
Revenue growth is +11.5% quarter-over-quarter, while maintaining an operating margin of +20.4% and return on equity of +12.1%.
Valuation Metrics
Market Cap
$4.94B
Enterprise Value
$5.05B
P/E Ratio
33.3x
PEG Ratio
1.7x
Price/Sales
4.9x
Growth & Margins
Revenue Growth (YoY)
+11.5%
Gross Margin
+36.4%
Operating Margin
+20.4%
Net Margin
+14.7%
EPS Growth
+19.1%
Financial Health
Cash/Price Ratio
+1.3%
Current Ratio
2.7x
Debt/Equity
13.3x
ROE
+12.1%
ROA
+7.9%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Balchem Corporation (BCPC) Business Model
About Balchem Corporation
What They Do
Produces specialty performance ingredients for health sectors.
Business Model
The company generates revenue through its diverse portfolio of specialty ingredients tailored for human and animal nutrition, as well as industrial applications. Balchem operates across multiple segments, including Human Nutrition & Health, Animal Nutrition & Health, Specialty Products, and Industrial Products, allowing it to cater to various industries and enhance product offerings.
Additional Information
Balchem is committed to sustainability and innovation, continually adapting to advancements in nutritional science and regulatory requirements. The company's focus on research and development positions it strategically in the market, addressing challenges related to health and environmental safety. Headquartered in New Hampton, New York, Balchem plays a pivotal role in promoting healthier living through its pioneering technologies.
Company Information
Sector
Basic Materials
Industry
Specialty Chemicals
Employees
1,364
CEO
Mr. Theodore Lee Harris
Country
United States
IPO Year
1986
Website
www.balchem.comBalchem Corporation (BCPC) Latest News & Analysis
Latest News
Balchem Corporation to Present at Baird's 55th Annual Global Industrial Conference on November 12, 2025
10 days ago
Quick Summary
Balchem Corporation (NASDAQ: BCPC) will present at Baird's 55th Annual Global Industrial Conference on November 12, 2025, as part of its engagement with the health and nutrition markets.
Why It Matters
Balchem's participation in a major conference highlights its market presence and could attract investor interest, potentially influencing stock performance and market perception.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Balchem's rating is upgraded from "Hold" to "Buy" after strong Q3 2025 results, driven by Human Nutrition and Specialty Products, with growth expected from new trends and a production plant.
Why It Matters
An upgraded rating to "Buy" indicates confidence in Balchem's growth potential, especially in key segments. Strong 3Q performance and favorable trends suggest future profitability.
Source: Seeking Alpha
Market Sentiment:
Positive
Why Balchem Stock Jumped Today
19 days ago
Quick Summary
Balchem achieved record sales in the third quarter and is actively pursuing new growth initiatives.
Why It Matters
Record sales indicate strong financial health and growth potential for Balchem, signaling a positive outlook that may attract investment and boost stock performance.
Source: The Motley Fool
Market Sentiment:
Positive
Quick Summary
Balchem Corporation (NASDAQ: BCPC) will hold its Q3 2025 earnings call on October 21, 2025, at 11:00 AM EDT, featuring key executives and analysts from various firms.
Why It Matters
The Q3 earnings call for Balchem Corporation will provide insights into financial performance and strategic direction, influencing stock valuation and investor sentiment.
Source: Seeking Alpha
Market Sentiment:
Neutral
Blachem (BCPC) Q3 Earnings Lag Estimates
19 days ago
Quick Summary
Blachem (BCPC) reported Q3 earnings of $1.35 per share, slightly below the Zacks Consensus Estimate of $1.36. This is an increase from $1.03 per share in the same quarter last year.
Why It Matters
Blachem's earnings miss signals potential operational challenges, affecting investor confidence and possibly leading to stock price volatility. Year-over-year growth may not offset the earnings disappointment.
Source: Zacks Investment Research
Market Sentiment:
Negative
Quick Summary
Balchem (BCPC) reported quarterly earnings of $1.35 per share, slightly below the Zacks Consensus Estimate of $1.36. This is an increase from $1.03 per share a year earlier.
Why It Matters
Balchem's earnings miss signals potential weaknesses in performance, which could impact investor confidence and stock price. Year-over-year growth may not offset the earnings shortfall.
Source: Zacks Investment Research
Market Sentiment:
Negative
Frequently Asked Questions About BCPC Stock
What is Balchem Corporation's (BCPC) stock forecast for 2026?
Based on our analysis of 3 Wall Street analysts, Balchem Corporation (BCPC) has a median price target of $192.00. The highest price target is $220.00 and the lowest is $190.00.
Is BCPC stock a good investment in 2026?
According to current analyst ratings, BCPC has 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $152.56. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for BCPC stock?
Wall Street analysts predict BCPC stock could reach $192.00 in the next 12 months. This represents a 25.9% increase from the current price of $152.56. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Balchem Corporation's business model?
The company generates revenue through its diverse portfolio of specialty ingredients tailored for human and animal nutrition, as well as industrial applications. Balchem operates across multiple segments, including Human Nutrition & Health, Animal Nutrition & Health, Specialty Products, and Industrial Products, allowing it to cater to various industries and enhance product offerings.
What is the highest forecasted price for BCPC Balchem Corporation?
The highest price target for BCPC is $220.00 from at , which represents a 44.2% increase from the current price of $152.56.
What is the lowest forecasted price for BCPC Balchem Corporation?
The lowest price target for BCPC is $190.00 from Raghuram Selvaraju at HC Wainwright & Co., which represents a 24.5% increase from the current price of $152.56.
What is the overall BCPC consensus from analysts for Balchem Corporation?
The overall analyst consensus for BCPC is bullish. Out of 3 Wall Street analysts, 2 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $192.00.
How accurate are BCPC stock price projections?
Stock price projections, including those for Balchem Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: November 9, 2025 10:07 AM UTC